Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Filings indexed 2,231 across all filing types
Latest filing 2025-02-26 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1789

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
113年第4季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for the fiscal period ending December 31, 2024 (民國113年第4季). It includes comprehensive financial statement line items such as assets, liabilities, and equity, with amounts and percentages. The document length is 3186 characters, which is relatively short but contains actual financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarterly period indicates this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. There is no indication that this is a certification, announcement, or other filing type. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2025-02-26 Chinese
公告本公司董事會決議召開114年股東常會
AGM Information Classification · 95% confidence The document is a public announcement from a listed company (1789 神隆) regarding the board of directors' resolution to convene the 114th Annual General Meeting (AGM). It includes details such as the date and location of the AGM, the agenda items including reports, approvals, and discussions to be held at the meeting. The document does not contain the actual AGM materials or reports but is an announcement about the AGM meeting itself. The document length is short (952 characters), consistent with an announcement rather than a full report. Therefore, this fits the category of AGM Information (AGM-R).
2025-02-26 Chinese
公告本公司董事會決議股利分派
Notice of Dividend Amount Classification · 95% confidence The document is a company announcement regarding the board of directors' resolution on dividend distribution for the fiscal year 113 (2024). It includes specific details about cash dividends per share, total dividend amount, and related dates. The document is short (766 characters) and focuses solely on dividend distribution details without containing full financial statements or comprehensive financial analysis. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2025-02-26 Chinese
113年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions and shareholder meetings, and explanations of dividend policies. It is a formal announcement of dividend amounts and payment details for shareholders. The document length is short (1917 characters) and focuses on dividend distribution specifics rather than a full financial report or earnings release. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-02-26 Chinese
公告本公司董事會通過113年度合併財務報告
Regulatory Filings Classification · 90% confidence The document is a public announcement from a listed company (1789 神隆) reporting that the board of directors has approved the consolidated financial report for the fiscal year 113 (2024). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity for the full year period 113/01/01 to 113/12/31. The document is short (908 characters) and primarily serves as an announcement of the approval of the annual consolidated financial report rather than the full report itself. There is no detailed financial statement or comprehensive analysis present, only key financial figures and approval dates. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a formal announcement of the board's approval of the annual financial report, not the full Annual Report (10-K) itself, nor a report publication announcement (RPA) since it contains substantive financial summary data rather than just a notice of publication.
2025-02-26 Chinese
公告本公司113年度財務報告董事會預計召開日期 為114年2月26日
Report Publication Announcement Classification · 95% confidence The document is a short announcement (542 characters) from a company (1789 神隆) stating the planned date for the board meeting to discuss the 113年度 (fiscal year 113) financial report. It includes the board meeting convocation date and the expected date of the meeting. There is no actual financial data or detailed report content included. The document is essentially a notice about the timing of the board meeting and the upcoming financial report, not the report itself. According to the 'MENU VS MEAL' rule, such short announcements about report timing are classified as Report Publication Announcements (RPA).
2025-02-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.